Lipocine Inc. Revenue 2012–2025
Lipocine Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Lipocine Inc. revenue for the quarter ending March 31, 2026 was 119397, a 27.20% increase year-over-year.
- Lipocine Inc. revenue for the twelve months ending March 31, 2026 was 950684, a 79.51% decrease year-over-year.
- Lipocine Inc. annual revenue for 2025 was 2.0 M, a 82.35% decrease from 2024.
- Lipocine Inc. annual revenue for 2024 was 11.2 M, a 492.80% decrease from 2023.
- Lipocine Inc. annual revenue for 2023 was -2.9 M, a 670.16% decrease from 2022.
- Lipocine Inc. annual revenue for 2022 was 500000.
Lipocine Inc. (LPCN) — Frequently Asked Questions
Lipocine Inc. (LPCN) is a publicly traded US company. It has a market capitalization of $13M. In fiscal 2025 it reported revenue of $2M and net income of -$10M. Explore LPCN's stock price, financial statements, earnings history, margins and key ratios below.
What is Lipocine Inc.'s market cap?
Lipocine Inc. (LPCN) has a market capitalization of $13M.
What is the LPCN stock price?
LPCN trades at $2.20 (+11.11% on the day).
How much revenue does Lipocine Inc. make?
Lipocine Inc. reported revenue of $2M in fiscal 2025.
Is LPCN profitable?
In fiscal 2025, Lipocine Inc. reported net income of -$10M.